REFERENCES
1. Lostchuck E, Poulton A, Halliday J, Hui L. Population-based trends in
invasive prenatal diagnosis for ultrasound-based indications: two
decades of change from 1994 to 2016. Ultrasound Obstet Gynecol.
2019;53:503-511.
2. Wang H, Dong Z, Zhang R, Chau MHK, Yang Z, Tsang KYC, et al. Low-pass
genome sequencing versus chromosomal microarray analysis: implementation
in prenatal diagnosis. Genet Med. 2020;22:500-510.
3. Martin AR, Atkinson EG, Chapman SB, Stevenson A, Stroud RE, Abebe T,
et al. Low-coverage sequencing cost-effectively detects known and novel
variation in underrepresented populations. Am J Hum Genet.
2021;108:656-668.
4. Dong Z, Zhang J, Hu P, Chen H, Xu J, Tian Q, et al. Low-pass
whole-genome sequencing in clinical cytogenetics: a validated approach.
Genet Med. 2016;18:940-948.
5. Wang J, Chen L, Zhou C, Wang L, Xie H, Xiao Y, et al. Prospective
chromosome analysis of 3429 amniocentesis samples in China using copy
number variation sequencing. Am J Obstet Gynecol. 2018;219:287 e281-287
e218.
6. Chau MHK, Wang H, Lai Y, Zhang Y, Xu F, Tang Y, et al. Low-pass
genome sequencing: a validated method in clinical cytogenetics. Hum
Genet. 2020;139:1403-1415.
7. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al.
Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl
J Med. 2012;367:2175-2184.
8. Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray
analysis. Fertil Steril. 2018;109:201-212.
9. Srebniak MI, Joosten M, Knapen M, Arends LR, Polak M, van Veen S, et
al. Frequency of submicroscopic chromosomal aberrations in pregnancies
without increased risk for structural chromosomal aberrations:
systematic review and meta-analysis. Ultrasound Obstet Gynecol.
2018;51:445-452.
10. Lin YH, Jong YJ, Huang PC, Tsai C. Detection of copy number variants
with chromosomal microarray in 10 377 pregnancies at a single
laboratory. Acta Obstet Gynecol Scand. 2020;99:775-782.
11. Sagi-Dain L, Cohen Vig L, Kahana S, Yacobson S, Tenne T,
Agmon-Fishman I, et al. Chromosomal microarray vs. NIPS: analysis of
5541 low-risk pregnancies. Genet Med. 2019;21:2462-2467.
12. Jansen FA, Blumenfeld YJ, Fisher A, Cobben JM, Odibo AO, Borrell A,
et al. Array comparative genomic hybridization and fetal congenital
heart defects: a systematic review and meta-analysis. Ultrasound Obstet
Gynecol. 2015;45:27-35.
13. Wang Y, Cao L, Liang D, Meng L, Wu Y, Qiao F, et al. Prenatal
chromosomal microarray analysis in fetuses with congenital heart
disease: a prospective cohort study. Am J Obstet Gynecol. 2018;218:244
e241-244 e217.
14. Society for Maternal-Fetal Medicine . Electronic address pso, Dugoff
L, Norton ME, Kuller JA. The use of chromosomal microarray for prenatal
diagnosis. Am J Obstet Gynecol. 2016;215:B2-9.
15. Su J, Qin Z, Fu H, Luo J, Huang Y, Huang P, et al. The correlations
of prenatal renal ultrasound abnormalities with pathogenic CNVs in a
large Chinese cohort. Ultrasound Obstet Gynecol. 2021.
16. Sagi-Dain L, Maya I, Reches A, Frumkin A, Grinshpun-Cohen J, Segel
R, et al. Chromosomal Microarray Analysis Results From Pregnancies With
Various Ultrasonographic Anomalies. Obstet Gynecol. 2018;132:1368-1375.
17. Santirocco M, Plaja A, Rodo C, Valenzuela I, Arevalo S, Castells N,
et al. Chromosomal microarray analysis in fetuses with central nervous
system anomalies: An 8-year long observational study from a tertiary
care university hospital. Prenat Diagn. 2021;41:123-135.
18. Sun L, Wu Q, Jiang SW, Yan Y, Wang X, Zhang J, et al. Prenatal
Diagnosis of Central Nervous System Anomalies by High-Resolution
Chromosomal Microarray Analysis. Biomed Res Int. 2015;2015:426379.
19. Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic
Disorders. Obstet Gynecol. 2016;127:e108-e122.
20. Grande M, Jansen FA, Blumenfeld YJ, Fisher A, Odibo AO, Haak MC, et
al. Genomic microarray in fetuses with increased nuchal translucency and
normal karyotype: a systematic review and meta-analysis. Ultrasound
Obstet Gynecol. 2015;46:650-658.
21. Egloff M, Herve B, Quibel T, Jaillard S, Le Bouar G, Uguen K, et al.
Diagnostic yield of chromosomal microarray analysis in fetuses with
isolated increased nuchal translucency: a French multicenter study.
Ultrasound Obstet Gynecol. 2018;52:715-721.
22. Chang Q, Yang Y, Peng Y, Liu S, Li L, Deng X, et al. Prenatal
detection of chromosomal abnormalities and copy number variants in
fetuses with ventriculomegaly. Eur J Paediatr Neurol. 2020;25:106-112.
23. Hu T, Tian T, Zhang Z, Wang J, Hu R, Xiao L, et al. Prenatal
chromosomal microarray analysis in 2466 fetuses with ultrasonographic
soft markers: a prospective cohort study. Am J Obstet Gynecol.
2021;224:516 e511-516 e516.
24. Society for Maternal-Fetal M, Electronic address pso, Fox NS,
Monteagudo A, Kuller JA, Craigo S, et al. Mild fetal ventriculomegaly:
diagnosis, evaluation, and management. Am J Obstet Gynecol.
2018;219:B2-B9.
25. Donnelly JC, Platt LD, Rebarber A, Zachary J, Grobman WA, Wapner RJ.
Association of copy number variants with specific ultrasonographically
detected fetal anomalies. Obstet Gynecol. 2014;124:83-90.
26. de Wit MC, Srebniak MI, Govaerts LC, Van Opstal D, Galjaard RJ, Go
AT. Additional value of prenatal genomic array testing in fetuses with
isolated structural ultrasound abnormalities and a normal karyotype: a
systematic review of the literature. Ultrasound Obstet Gynecol.
2014;43:139-146.
27. Chong HP, Hamilton S, Mone F, Cheung KW, Togneri FS, Morris RK, et
al. Prenatal chromosomal microarray testing of fetuses with ultrasound
structural anomalies: A prospective cohort study of over 1000
consecutive cases. Prenat Diagn. 2019;39:1064-1069.
28. Zhou X, Chen X, Jiang Y, Qi Q, Hao N, Liu C, et al. A Rapid PCR-Free
Next-Generation Sequencing Method for the Detection of Copy Number
Variations in Prenatal Samples. Life (Basel). 2021;11.
29. Liang D, Peng Y, Lv W, Deng L, Zhang Y, Li H, et al. Copy number
variation sequencing for comprehensive diagnosis of chromosome disease
syndromes. J Mol Diagn. 2014;16:519-526.
30. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.
Standards and guidelines for the interpretation of sequence variants: a
joint consensus recommendation of the American College of Medical
Genetics and Genomics and the Association for Molecular Pathology. Genet
Med. 2015;17:405-424.
31. Grati FR, Molina Gomes D, Ferreira JC, Dupont C, Alesi V, Gouas L,
et al. Prevalence of recurrent pathogenic microdeletions and
microduplications in over 9500 pregnancies. Prenat Diagn.
2015;35:801-809.
32. Van Buggenhout G, Melotte C, Dutta B, Froyen G, Van Hummelen P,
Marynen P, et al. Mild Wolf-Hirschhorn syndrome: micro-array CGH
analysis of atypical 4p16.3 deletions enables refinement of the
genotype-phenotype map. J Med Genet. 2004;41:691-698.
33. Engbers H, van der Smagt JJ, van ’t Slot R, Vermeesch JR,
Hochstenbach R, Poot M. Wolf-Hirschhorn syndrome facial dysmorphic
features in a patient with a terminal 4p16.3 deletion telomeric to the
WHSCR and WHSCR 2 regions. Eur J Hum Genet. 2009;17:129-132.
34. Talkowski ME, Rehm HL. Introduction of genomics into prenatal
diagnostics. Lancet. 2019;393:719-721.
35. Lord J, McMullan DJ, Eberhardt RY, Rinck G, Hamilton SJ,
Quinlan-Jones E, et al. Prenatal exome sequencing analysis in fetal
structural anomalies detected by ultrasonography (PAGE): a cohort study.
Lancet. 2019;393:747-757.
36. Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, et
al. Whole-exome sequencing in the evaluation of fetal structural
anomalies: a prospective cohort study. Lancet. 2019;393:758-767.
37. Adams AD, Stover S, Rac MW. Omphalocele-What should we tell the
prospective parents? Prenat Diagn. 2021;41:486-496.
38. Sinajon P, Chitayat D, Roifman M, Wasim S, Carmona S, Ryan G, et al.
Microarray and RASopathy-disorder testing in fetuses with increased
nuchal translucency. Ultrasound Obstet Gynecol. 2020;55:383-390.
39. Huang RN, Chen JY, Pan H, Liu QQ. Correlation between mild fetal
ventriculomegaly, chromosomal abnormalities, and copy number variations.
J Matern Fetal Neonatal Med. 2022;35:4788-4796.
40. Society for Maternal-Fetal Medicine . Electronic address pso, Prabhu
M, Kuller JA, Biggio JR. Society for Maternal-Fetal Medicine Consult
Series #57: Evaluation and management of isolated soft ultrasound
markers for aneuploidy in the second trimester: (Replaces Consults #10,
Single umbilical artery, October 2010; #16, Isolated echogenic bowel
diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation
and management of isolated renal pelviectasis on second-trimester
ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts,
April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
Am J Obstet Gynecol. 2021;225:B2-B15.
41. Zhao Y, Diacou A, Johnston HR, Musfee FI, McDonald-McGinn DM, McGinn
D, et al. Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with
22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart
Defects. Am J Hum Genet. 2020;106:26-40.
42. Collins RT, 2nd. Cardiovascular disease in Williams syndrome.
Circulation. 2013;127:2125-2134.
43. Verbitsky M, Westland R, Perez A, Kiryluk K, Liu Q, Krithivasan P,
et al. The copy number variation landscape of congenital anomalies of
the kidney and urinary tract. Nat Genet. 2019;51:117-127.
44. Battaglia A, Carey JC, South ST. Wolf-Hirschhorn syndrome: A review
and update. Am J Med Genet C Semin Med Genet. 2015;169:216-223.